Concise review

Emerging concepts in clinical targeting of cancer stem cells

Zeshaan A. Rasheed, Jeanne Kowalski, B Douglas Smith, William Matsui

Research output: Contribution to journalArticle

Abstract

Cancer stem cells (CSCs) are functionally defined by their ability to self-renew and recapitulate tumors in the ectopic setting. They have been identified in a growing number of human malignancies and their association with poor clinical outcomes has suggested that they are the major factors in dictating clinical outcomes. Moreover, recent studies have demonstrated that CSCs may display other functional attributes, such as drug resistance and invasion and migration, that implicate a broad role in clinical oncology spanning initial tumor formation, relapse following treatment, and disease progression. Although our knowledge regarding the basic biology of CSCs continues to improve, proof that they are clinically relevant is still lacking, and translation of the CSC hypothesis from the laboratory to the clinic is of paramount importance. We will review current evidence supporting the role of CSCs in clinical oncology and discuss potential barriers and strategies in designing trials examining CSC-targeting agents.

Original languageEnglish (US)
Pages (from-to)883-887
Number of pages5
JournalStem Cells
Volume29
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Neoplastic Stem Cells
Medical Oncology
Neoplasms
Drug Resistance
Disease Progression
Recurrence

Keywords

  • Antineoplastic agents
  • Cancer stem cells
  • Drug resistance
  • Metastasis

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Medicine

Cite this

Concise review : Emerging concepts in clinical targeting of cancer stem cells. / Rasheed, Zeshaan A.; Kowalski, Jeanne; Smith, B Douglas; Matsui, William.

In: Stem Cells, Vol. 29, No. 6, 06.2011, p. 883-887.

Research output: Contribution to journalArticle

Rasheed, Zeshaan A. ; Kowalski, Jeanne ; Smith, B Douglas ; Matsui, William. / Concise review : Emerging concepts in clinical targeting of cancer stem cells. In: Stem Cells. 2011 ; Vol. 29, No. 6. pp. 883-887.
@article{12dee877d1154ee69d0118b0b23f7b1c,
title = "Concise review: Emerging concepts in clinical targeting of cancer stem cells",
abstract = "Cancer stem cells (CSCs) are functionally defined by their ability to self-renew and recapitulate tumors in the ectopic setting. They have been identified in a growing number of human malignancies and their association with poor clinical outcomes has suggested that they are the major factors in dictating clinical outcomes. Moreover, recent studies have demonstrated that CSCs may display other functional attributes, such as drug resistance and invasion and migration, that implicate a broad role in clinical oncology spanning initial tumor formation, relapse following treatment, and disease progression. Although our knowledge regarding the basic biology of CSCs continues to improve, proof that they are clinically relevant is still lacking, and translation of the CSC hypothesis from the laboratory to the clinic is of paramount importance. We will review current evidence supporting the role of CSCs in clinical oncology and discuss potential barriers and strategies in designing trials examining CSC-targeting agents.",
keywords = "Antineoplastic agents, Cancer stem cells, Drug resistance, Metastasis",
author = "Rasheed, {Zeshaan A.} and Jeanne Kowalski and Smith, {B Douglas} and William Matsui",
year = "2011",
month = "6",
doi = "10.1002/stem.648",
language = "English (US)",
volume = "29",
pages = "883--887",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Concise review

T2 - Emerging concepts in clinical targeting of cancer stem cells

AU - Rasheed, Zeshaan A.

AU - Kowalski, Jeanne

AU - Smith, B Douglas

AU - Matsui, William

PY - 2011/6

Y1 - 2011/6

N2 - Cancer stem cells (CSCs) are functionally defined by their ability to self-renew and recapitulate tumors in the ectopic setting. They have been identified in a growing number of human malignancies and their association with poor clinical outcomes has suggested that they are the major factors in dictating clinical outcomes. Moreover, recent studies have demonstrated that CSCs may display other functional attributes, such as drug resistance and invasion and migration, that implicate a broad role in clinical oncology spanning initial tumor formation, relapse following treatment, and disease progression. Although our knowledge regarding the basic biology of CSCs continues to improve, proof that they are clinically relevant is still lacking, and translation of the CSC hypothesis from the laboratory to the clinic is of paramount importance. We will review current evidence supporting the role of CSCs in clinical oncology and discuss potential barriers and strategies in designing trials examining CSC-targeting agents.

AB - Cancer stem cells (CSCs) are functionally defined by their ability to self-renew and recapitulate tumors in the ectopic setting. They have been identified in a growing number of human malignancies and their association with poor clinical outcomes has suggested that they are the major factors in dictating clinical outcomes. Moreover, recent studies have demonstrated that CSCs may display other functional attributes, such as drug resistance and invasion and migration, that implicate a broad role in clinical oncology spanning initial tumor formation, relapse following treatment, and disease progression. Although our knowledge regarding the basic biology of CSCs continues to improve, proof that they are clinically relevant is still lacking, and translation of the CSC hypothesis from the laboratory to the clinic is of paramount importance. We will review current evidence supporting the role of CSCs in clinical oncology and discuss potential barriers and strategies in designing trials examining CSC-targeting agents.

KW - Antineoplastic agents

KW - Cancer stem cells

KW - Drug resistance

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=79957622341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957622341&partnerID=8YFLogxK

U2 - 10.1002/stem.648

DO - 10.1002/stem.648

M3 - Article

VL - 29

SP - 883

EP - 887

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 6

ER -